Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe
The Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe, commonly referred to as the Paul-Ehrlich-Institut (PEI), is a prominent medical laboratory based in Germany. Established in 1891, the institute has played a pivotal role in the development and regulation of vaccines and biomedicines, ensuring public health safety across the nation and beyond.
Headquartered in Langen, the PEI operates primarily within the medical laboratories sector, focusing on the research, testing, and approval of sera and vaccines. Its unique position as a federal agency allows it to maintain rigorous standards in the evaluation of biological products, contributing significantly to Germany's reputation in the global health landscape. Notable achievements include its involvement in the rapid development of COVID-19 vaccines, underscoring its commitment to innovation and public health.
+2 vs industry average
Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe’s score of 25 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Laboratories has below-average carbon intensity
Industry performance
The Medical Laboratories industry has reduced its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe's reported carbon emissions
The Paul-Ehrlich-Institut (PEI), a Bundesamt für Sera und Impfstoffe located in DE and operating within the Medical Laboratories industry, reported a total of approximately 8,097 kg CO2e in 2024. This figure comprises about 3,650,000 kg CO2e from Scope 1 emissions and approximately 6,420 kg CO2e from Scope 2 emissions, along with roughly 1,640 kg CO2e from Scope 3 emissions. In 2023, the PEI's total emissions were approximately 7,785 kg CO2e, with Scope 1 contributing about 2,216,000 kg CO2e, Scope 2 around 6,401 kg CO2e, and Scope 3 approximately 1,362 kg CO2e. For 2022, the institute's total emissions were reported as approximately 8,133 kg CO2e, including Scope 1 emissions of about 1,593,000 kg CO2e, Scope 2 emissions of approximately 6,851 kg CO2e, and Scope 3 emissions of roughly 1,266 kg CO2e. In 2021, the PEI's total emissions stood at approximately 7,629 kg CO2e. This included Scope 1 emissions of about 2,425,000 kg CO2e, Scope 2 emissions of approximately 7,346 kg CO2e, and a significant Scope 3 figure of roughly 25,794,000 kg CO2e. The PEI's data indicates disclosure across all three scopes (Scope 1, 2, and 3). However, specific data points within Scope 3, such as purchased goods and services, were noted as missing. The organisation does not currently have publicly stated reduction targets or commitments through initiatives like the Science Based Targets initiative (SBTi) or the Climate Pledge.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Paul-Ehrlich-Institut Bundesamt Fuer Sera Und Impfstoffe yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project